This section will contain updates from the pain industry.

AAPM 2020 Resource Center Opportunities

Exhibits, scientific posters, attendee receptions, Meet the Faculty events, and much more are planned for the AAPM 2020 Resource Center. Attendees will have opportunities to connect with colleagues and learn about the la...
Continue reading
Topics:

New Novartis Medicine Adakveo® (crizanlizumab) Approved by FDA to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease

  Read the full story.
Topics:
FDA

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

 BioElectronics Corporation, the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management , titled " A Prospective Six-Month S...
Continue reading

FDA Approves New Treatment for Patients with Migraine

The U.S. Food and Drug Administration approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow i...
Continue reading
Topics:

AI-Powered Motion Tracking Technology for Back Pain and COPD: Interview with Rutger Flohil, US CEO of Kaia Health

Kaia Health, a health technology company based in New York City, has developed a smartphone app that can guide users through exercises to help with back pain and COPD. The technology uses AI powered motion tracking techn...
Continue reading

ATI Physical Therapy Launches ATIFirst Program and Outcomes and Best Practices Initiative

Physical therapy first offers faster diagnosis and treatment, lower health care costs and no drugs needed. Industry is beginning to shift its view of the value of using physical therapy first for chronic musculoskeletal pain conditions. 

Continue reading

FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life for People Living with Chronic Pain

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform o...
Continue reading

eMindful Introduces Mindfulness Program for Chronic Pain

  eMindful , a leading provider of purpose-driven mindfulness solutions that improve health and productivity and lower healthcare costs, today announced the launch of its program for people with chronic pain. The pr...
Continue reading
Topics:

Innovative Technique Uses Neuro-Response Testing to Resolve Chronic Pain

In Boulder, Colorado, athletes and older adults suffering from chronic pain have been praising a new healing modality called the "Square 1 System." Nile Bratcher, movement coach and rehabilitation professional who specia...
Continue reading

Could a Blood Test Measure Your Pain and Mood? One Startup Believes It Can

A medical startup called MindX Sciences are working to develop a blood test using biomarker technology for those conditions that have previously been so hard to measure, including pain.   Full story.
Topics:

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More